AZTA
Price
$49.08
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
54 days until earnings call
BLFS
Price
$23.45
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
50 days until earnings call
Ad is loading...

AZTA vs BLFS

Header iconAZTA vs BLFS Comparison
Open Charts AZTA vs BLFSBanner chart's image
Azenta
Price$49.08
Change-$0.00 (-0.00%)
Volume$599.69K
CapitalizationN/A
BioLife Solutions
Price$23.45
Change-$0.00 (-0.00%)
Volume$503.92K
CapitalizationN/A
View a ticker or compare two or three
AZTA vs BLFS Comparison Chart
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AZTA vs. BLFS commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and BLFS is a StrongSell.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (AZTA: $49.08 vs. BLFS: $23.45)
Brand notoriety: AZTA and BLFS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 104% vs. BLFS: 152%
Market capitalization -- AZTA: $3.36B vs. BLFS: $810.87M
AZTA [@Medical Specialties] is valued at $3.36B. BLFS’s [@Medical Specialties] market capitalization is $810.87M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • BLFS’s FA Score: 1 green, 4 red.
According to our system of comparison, BLFS is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while BLFS’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 5 bearish.
  • BLFS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than BLFS.

Price Growth

AZTA (@Medical Specialties) experienced а +7.07% price change this week, while BLFS (@Medical Specialties) price change was -1.10% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.43%. For the same industry, the average monthly price growth was +0.16%, and the average quarterly price growth was -3.16%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 11, 2024.

BLFS is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Medical Specialties (+1.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than BLFS($811M). BLFS YTD gains are higher at: 44.308 vs. AZTA (-24.655). AZTA has higher annual earnings (EBITDA): 57.5M vs. BLFS (-45.24M). AZTA has more cash in the bank: 984M vs. BLFS (51.7M). BLFS has less debt than AZTA: BLFS (42.7M) vs AZTA (66.5M). AZTA has higher revenues than BLFS: AZTA (641M) vs BLFS (143M).
AZTABLFSAZTA / BLFS
Capitalization3.36B811M415%
EBITDA57.5M-45.24M-127%
Gain YTD-24.65544.308-56%
P/E RatioN/A238.10-
Revenue641M143M448%
Total Cash984M51.7M1,903%
Total Debt66.5M42.7M156%
FUNDAMENTALS RATINGS
AZTA vs BLFS: Fundamental Ratings
AZTA
BLFS
OUTLOOK RATING
1..100
510
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
7588
SMR RATING
1..100
9395
PRICE GROWTH RATING
1..100
7738
P/E GROWTH RATING
1..100
6820
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (66) in the Electronic Production Equipment industry is in the same range as BLFS (95) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BLFS’s over the last 12 months.

AZTA's Profit vs Risk Rating (75) in the Electronic Production Equipment industry is in the same range as BLFS (88) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BLFS’s over the last 12 months.

AZTA's SMR Rating (93) in the Electronic Production Equipment industry is in the same range as BLFS (95) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Price Growth Rating (38) in the Medical Specialties industry is somewhat better than the same rating for AZTA (77) in the Electronic Production Equipment industry. This means that BLFS’s stock grew somewhat faster than AZTA’s over the last 12 months.

BLFS's P/E Growth Rating (20) in the Medical Specialties industry is somewhat better than the same rating for AZTA (68) in the Electronic Production Equipment industry. This means that BLFS’s stock grew somewhat faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTABLFS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 3 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
82%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRZVX57.500.37
+0.65%
T. Rowe Price Small-Cap Value Z
BUITX25.280.05
+0.20%
Buffalo Mid Cap Discovery Inst
GILAX13.270.02
+0.15%
Lord Abbett Fundamental Equity C
MVSNX24.44N/A
N/A
Mar Vista Strategic Growth Investor
PJGCX14.79-0.03
-0.20%
PGIM Jennison Focused Value C